CD34 and breast cancer: To confirm the specific expression of ARG2 in CML progenitors, we treated CD34+ cells from normal cord blood (CB), chronic phase (CP) and blast crisis (BC) CML samples under normoxia (21% O2) or hypoxia (0.5 to 2% O2).